Skip to main content

Akebia Therapeutics, Inc 10-Q for FY2024 Q2

Akebia Therapeutics, Inc. (AKBA)

10-Q 2024-08-08 For: 2024-06-30
View Original
Added on April 11, 2026

About this 10-Q

Akebia Therapeutics, Inc filed this 10-Q on August 8, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$43.65M
down 22.6% from $56.38M a year earlier
Net loss
$8.58M
compared with a net loss of $11.17M a year earlier
Diluted EPS
-$0.04
compared with -$0.06 a year earlier